|
| 亚虹医药-U(688176)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-07 | 12946.53 | 22.71% | 56398.08 | 601.92 | 37148.05 | 65.17% | 追加承诺限售股份上市流通 | | 2025-01-07 | 6303.50 | 11.06% | 43451.55 | 13548.45 | 36818.05 | 64.59% | 首发原股东限售股份 | | 2024-01-08 | 330.00 | 0.58% | 37148.05 | 19851.95 | 23383.81 | 41.02% | 首发战略配售股份 | | 2023-10-19 | 8858.38 | 15.54% | 36818.05 | 20181.95 | 23383.81 | 41.02% | 首发原股东限售股份 | | 2023-07-10 | 4575.86 | 8.03% | 27959.67 | 29040.33 | 23383.81 | 41.02% | 首发原股东限售股份 | | 2023-01-09 | 12713.81 | 22.30% | 23383.81 | 33616.19 | 23383.81 | 41.02% | 首发原股东限售股份 | | 2022-07-07 | 592.60 | 1.04% | 10670.00 | 46330.00 | 10670.00 | 18.72% | 首发机构配售股份 | | 2022-01-07 | 10077.40 | 17.68% | 10077.40 | 46922.60 | 10077.40 | 17.68% | 首发一般股份 |
|